○Yuko Kanbayashi^1,2,3, Fumimasa Amaya⁴, Kazuya Ikoma⁵, Hiroshi Ueno⁴, Yusuke Tabuchi², Takeshi Ishikawa^2,6, Koichi Takayama⁷, Tetsuya Taguchi^2,3 (1. Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, 2. Outpatient Oncology Unit, University Hospital, Kyoto Prefectural University of Medicine, 3. Endocrine and Breast Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 4. Pain Treatment and Palliative Care Unit, University Hospital, Kyoto Prefectural University of Medicine, 5. Orthopaedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 6. Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 7. Pulmonary Medicine, Kyoto Prefectural University of Medicine)

○Fumio Matsui¹, Naoko Hayashi^1,2, Hiroki Iwata^1,2, Noriko Kobayashi^1,2, Kazuko Fujimoto¹, Katsunori Yamaura^1,2 (1. Keio Univ Faculty Pharm., 2. Keio Univ Commun Pharm.)

○Ayano Okabe¹, Manabu Akazawa², Hideki Maeda¹ (1. Dept. Regulatory Science, Meiji Pharm Univ., 2. Dept. Public Health and Epidemiology, Meiji Pharm Univ.)

○Haru Iino¹, Masayuki Hashiguchi¹, Satoko Hori¹ (1. Fac of Pharmacy. Keio Univ.)

○Natsuyo Yanagi¹, Hiroki Satoh¹, Yasufumi Sawada¹ (1. Grad.Sch.Pharm. Sci., Univ. Tokyo)